
Procter & Gamble Health Ltd has announced an interim dividend of ₹160 per equity share for the financial year 2025–26.
This payout includes a regular interim dividend of ₹110 per share along with a one-time special dividend of ₹50 per share. Investors holding shares before the record date will be eligible to receive the dividend.
The company has fixed February 12, 2026, as the record date to determine eligible shareholders for receiving the dividend. Investors must hold shares in their demat accounts by the end of this date to qualify.
The dividend payment is scheduled to be completed on or before March 4, 2026. Shares typically trade ex-dividend before the record date, meaning investors purchasing shares after the ex-date will not receive the payout.
Procter & Gamble Health has maintained a consistent dividend payment history. In August 2025, the company paid a final dividend of ₹45 per share. Earlier in February 2025, shareholders received an interim dividend of ₹80 per share. The addition of a special dividend this year highlights strong cash generation and management’s willingness to distribute surplus funds to investors.
Procter & Gamble Health reported strong financial results for the quarter ended December 31, 2025, with sales rising 21% year-on-year to ₹368 crore, supported by strong brand performance and positive consumer response to new product innovations.
Profit After Tax for the quarter stood at ₹78 crore, reflecting steady operational execution and sustained demand across key product categories.
Also Read: Best Long-Term Stocks in Feb 2026!
Procter & Gamble Health’s interim dividend announcement, including the special payout, reinforces its shareholder-friendly approach. With the record date approaching, eligible investors can look forward to receiving the dividend payout in early March, making the stock a focus for income-seeking investors. Shareholders must hold shares in a valid demat account as of the record date to be eligible for the dividend.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 11, 2026, 8:57 AM IST

Nikitha Devi
Nikitha is a content creator with 7+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
